Nova BioPharma Limited   Report issue

For profit Phase 2
Founded: Wigston United Kingdom (1994)

Organization Overview

First Clinical Trial
2018
NCT03291080
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Nova BioPharma Limited

Active Ingredients

Drugs in Phase 2 Trials (1)

13-cis-retinoic Acid (Zenatane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1